Corcept Therapeutics Incorporated (Nasdaq: CORT) is a commercial-stage biopharmaceutical company that discovers, develops and commercializes drugs modulating cortisol activity at the glucocorticoid receptor to treat severe metabolic, oncolo…
HQ: Redwood City, CA, United States of Americawww.corcept.com
USD112.79-1.85%vs prev. close
Market snapshot
Price
USD112.79
Daily move
-1.85%
P/E
250.6
EPS TTM
0.45
Dividend yield
—
Beta
0.45
Market cap
12.2B
Price history
CORT price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Corcept Therapeutics
CORT
Biotechnology
12.2
250.6
—
+1.1%
+0.5%
+36.0%
+250.8%
+51.7%
+224.1%
🔒
Subscribe to Equity Analytics to compare CORT with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.